Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark. / Fogh, Kamille; Eriksen, Alexandra R. R.; Hasselbalch, Rasmus B.; Kristensen, Emilie Sofie; Bundgaard, Henning; Nielsen, Susanne D.; Jorgensen, Charlotte S.; Scharff, Bibi F. S. S.; Erikstrup, Christian; Saekmose, Susanne G.; Holm, Dorte K.; Aagaard, Bitten; Norsk, Jakob; Nielsen, Pernille Brok; Kristensen, Jonas H.; Østergaard, Lars; Ellermann-Eriksen, Svend; Andersen, Berit; Nielsen, Henrik; Johansen, Isik S.; Wiese, Lothar; Simonsen, Lone; Fischer, Thea K.; Folke, Fredrik; Lippert, Freddy; Ostrowski, Sisse R.; Ethelberg, Steen; Koch, Anders; Vangsted, Anne-Marie; Krause, Tyra Grove; Fomsgaard, Anders; Nielsen, Claus; Ullum, Henrik; Skov, Robert; Iversen, Kasper.

In: BMC Infectious Diseases, Vol. 22, No. 1, 143, 2022.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Fogh, K, Eriksen, ARR, Hasselbalch, RB, Kristensen, ES, Bundgaard, H, Nielsen, SD, Jorgensen, CS, Scharff, BFSS, Erikstrup, C, Saekmose, SG, Holm, DK, Aagaard, B, Norsk, J, Nielsen, PB, Kristensen, JH, Østergaard, L, Ellermann-Eriksen, S, Andersen, B, Nielsen, H, Johansen, IS, Wiese, L, Simonsen, L, Fischer, TK, Folke, F, Lippert, F, Ostrowski, SR, Ethelberg, S, Koch, A, Vangsted, A-M, Krause, TG, Fomsgaard, A, Nielsen, C, Ullum, H, Skov, R & Iversen, K 2022, 'Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark', BMC Infectious Diseases, vol. 22, no. 1, 143. https://doi.org/10.1186/s12879-022-07102-1

APA

Fogh, K., Eriksen, A. R. R., Hasselbalch, R. B., Kristensen, E. S., Bundgaard, H., Nielsen, S. D., Jorgensen, C. S., Scharff, B. F. S. S., Erikstrup, C., Saekmose, S. G., Holm, D. K., Aagaard, B., Norsk, J., Nielsen, P. B., Kristensen, J. H., Østergaard, L., Ellermann-Eriksen, S., Andersen, B., Nielsen, H., ... Iversen, K. (2022). Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark. BMC Infectious Diseases, 22(1), [143]. https://doi.org/10.1186/s12879-022-07102-1

Vancouver

Fogh K, Eriksen ARR, Hasselbalch RB, Kristensen ES, Bundgaard H, Nielsen SD et al. Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark. BMC Infectious Diseases. 2022;22(1). 143. https://doi.org/10.1186/s12879-022-07102-1

Author

Fogh, Kamille ; Eriksen, Alexandra R. R. ; Hasselbalch, Rasmus B. ; Kristensen, Emilie Sofie ; Bundgaard, Henning ; Nielsen, Susanne D. ; Jorgensen, Charlotte S. ; Scharff, Bibi F. S. S. ; Erikstrup, Christian ; Saekmose, Susanne G. ; Holm, Dorte K. ; Aagaard, Bitten ; Norsk, Jakob ; Nielsen, Pernille Brok ; Kristensen, Jonas H. ; Østergaard, Lars ; Ellermann-Eriksen, Svend ; Andersen, Berit ; Nielsen, Henrik ; Johansen, Isik S. ; Wiese, Lothar ; Simonsen, Lone ; Fischer, Thea K. ; Folke, Fredrik ; Lippert, Freddy ; Ostrowski, Sisse R. ; Ethelberg, Steen ; Koch, Anders ; Vangsted, Anne-Marie ; Krause, Tyra Grove ; Fomsgaard, Anders ; Nielsen, Claus ; Ullum, Henrik ; Skov, Robert ; Iversen, Kasper. / Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark. In: BMC Infectious Diseases. 2022 ; Vol. 22, No. 1.

Bibtex

@article{611bb327fd2c44cd9d19eefebd62a2a7,
title = "Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark",
abstract = "Background COVID-19 is thought to be more prevalent among ethnic minorities and individuals with low socioeconomic status. We aimed to investigate the prevalence of SARS-CoV-2 antibodies during the COVID-19 pandemic among citizens 15 years or older in Denmark living in social housing (SH) areas. Methods We conducted a study between January 8th and January 31st, 2021 with recruitment in 13 selected SH areas. Participants were offered a point-of-care rapid SARS-CoV-2 IgM and IgG antibody test and a questionnaire concerning risk factors associated with COVID-19. As a proxy for the general Danish population we accessed data on seroprevalence from Danish blood donors (total Ig ELISA assay) in same time period. Results Of the 13,279 included participants, 2296 (17.3%) were seropositive (mean age 46.6 (SD 16.4) years, 54.2% female), which was 3 times higher than in the general Danish population (mean age 41.7 (SD 14.1) years, 48.5% female) in the same period (5.8%, risk ratios (RR) 2.96, 95% CI 2.78-3.16, p > 0.001). Seropositivity was higher among males (RR 1.1, 95% CI 1.05-1.22%, p = 0.001) and increased with age, with an OR seropositivity of 1.03 for each 10-year increase in age (95% CI 1.00-1.06, p = 0.031). Close contact with COVID-19-infected individuals was associated with a higher risk of infection, especially among household members (OR 5.0, 95% CI 4.1-6.2 p < 0,001). Living at least four people in a household significantly increased the OR of seropositivity (OR 1.3, 95% CI 1.0-1.6, p = 0.02) as did living in a multi-generational household (OR 1.3 per generation, 95% CI 1.1-1.6, p = 0.003). Only 1.6% of participants reported not following any of the national COVID-19 recommendations. Conclusions Danish citizens living in SH areas of low socioeconomic status had a three times higher SARS-CoV-2 seroprevalence compared to the general Danish population. The seroprevalence was significantly higher in males and increased slightly with age. Living in multiple generations households or in households of more than four persons was a strong risk factor for being seropositive. Results of this study can be used for future consideration of the need for preventive measures in the populations living in SH areas.",
keywords = "SARS-CoV-2, COVID-19, Seroprevalence, Social housing areas, Antibodies",
author = "Kamille Fogh and Eriksen, {Alexandra R. R.} and Hasselbalch, {Rasmus B.} and Kristensen, {Emilie Sofie} and Henning Bundgaard and Nielsen, {Susanne D.} and Jorgensen, {Charlotte S.} and Scharff, {Bibi F. S. S.} and Christian Erikstrup and Saekmose, {Susanne G.} and Holm, {Dorte K.} and Bitten Aagaard and Jakob Norsk and Nielsen, {Pernille Brok} and Kristensen, {Jonas H.} and Lars {\O}stergaard and Svend Ellermann-Eriksen and Berit Andersen and Henrik Nielsen and Johansen, {Isik S.} and Lothar Wiese and Lone Simonsen and Fischer, {Thea K.} and Fredrik Folke and Freddy Lippert and Ostrowski, {Sisse R.} and Steen Ethelberg and Anders Koch and Anne-Marie Vangsted and Krause, {Tyra Grove} and Anders Fomsgaard and Claus Nielsen and Henrik Ullum and Robert Skov and Kasper Iversen",
year = "2022",
doi = "10.1186/s12879-022-07102-1",
language = "English",
volume = "22",
journal = "B M C Infectious Diseases",
issn = "1471-2334",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark

AU - Fogh, Kamille

AU - Eriksen, Alexandra R. R.

AU - Hasselbalch, Rasmus B.

AU - Kristensen, Emilie Sofie

AU - Bundgaard, Henning

AU - Nielsen, Susanne D.

AU - Jorgensen, Charlotte S.

AU - Scharff, Bibi F. S. S.

AU - Erikstrup, Christian

AU - Saekmose, Susanne G.

AU - Holm, Dorte K.

AU - Aagaard, Bitten

AU - Norsk, Jakob

AU - Nielsen, Pernille Brok

AU - Kristensen, Jonas H.

AU - Østergaard, Lars

AU - Ellermann-Eriksen, Svend

AU - Andersen, Berit

AU - Nielsen, Henrik

AU - Johansen, Isik S.

AU - Wiese, Lothar

AU - Simonsen, Lone

AU - Fischer, Thea K.

AU - Folke, Fredrik

AU - Lippert, Freddy

AU - Ostrowski, Sisse R.

AU - Ethelberg, Steen

AU - Koch, Anders

AU - Vangsted, Anne-Marie

AU - Krause, Tyra Grove

AU - Fomsgaard, Anders

AU - Nielsen, Claus

AU - Ullum, Henrik

AU - Skov, Robert

AU - Iversen, Kasper

PY - 2022

Y1 - 2022

N2 - Background COVID-19 is thought to be more prevalent among ethnic minorities and individuals with low socioeconomic status. We aimed to investigate the prevalence of SARS-CoV-2 antibodies during the COVID-19 pandemic among citizens 15 years or older in Denmark living in social housing (SH) areas. Methods We conducted a study between January 8th and January 31st, 2021 with recruitment in 13 selected SH areas. Participants were offered a point-of-care rapid SARS-CoV-2 IgM and IgG antibody test and a questionnaire concerning risk factors associated with COVID-19. As a proxy for the general Danish population we accessed data on seroprevalence from Danish blood donors (total Ig ELISA assay) in same time period. Results Of the 13,279 included participants, 2296 (17.3%) were seropositive (mean age 46.6 (SD 16.4) years, 54.2% female), which was 3 times higher than in the general Danish population (mean age 41.7 (SD 14.1) years, 48.5% female) in the same period (5.8%, risk ratios (RR) 2.96, 95% CI 2.78-3.16, p > 0.001). Seropositivity was higher among males (RR 1.1, 95% CI 1.05-1.22%, p = 0.001) and increased with age, with an OR seropositivity of 1.03 for each 10-year increase in age (95% CI 1.00-1.06, p = 0.031). Close contact with COVID-19-infected individuals was associated with a higher risk of infection, especially among household members (OR 5.0, 95% CI 4.1-6.2 p < 0,001). Living at least four people in a household significantly increased the OR of seropositivity (OR 1.3, 95% CI 1.0-1.6, p = 0.02) as did living in a multi-generational household (OR 1.3 per generation, 95% CI 1.1-1.6, p = 0.003). Only 1.6% of participants reported not following any of the national COVID-19 recommendations. Conclusions Danish citizens living in SH areas of low socioeconomic status had a three times higher SARS-CoV-2 seroprevalence compared to the general Danish population. The seroprevalence was significantly higher in males and increased slightly with age. Living in multiple generations households or in households of more than four persons was a strong risk factor for being seropositive. Results of this study can be used for future consideration of the need for preventive measures in the populations living in SH areas.

AB - Background COVID-19 is thought to be more prevalent among ethnic minorities and individuals with low socioeconomic status. We aimed to investigate the prevalence of SARS-CoV-2 antibodies during the COVID-19 pandemic among citizens 15 years or older in Denmark living in social housing (SH) areas. Methods We conducted a study between January 8th and January 31st, 2021 with recruitment in 13 selected SH areas. Participants were offered a point-of-care rapid SARS-CoV-2 IgM and IgG antibody test and a questionnaire concerning risk factors associated with COVID-19. As a proxy for the general Danish population we accessed data on seroprevalence from Danish blood donors (total Ig ELISA assay) in same time period. Results Of the 13,279 included participants, 2296 (17.3%) were seropositive (mean age 46.6 (SD 16.4) years, 54.2% female), which was 3 times higher than in the general Danish population (mean age 41.7 (SD 14.1) years, 48.5% female) in the same period (5.8%, risk ratios (RR) 2.96, 95% CI 2.78-3.16, p > 0.001). Seropositivity was higher among males (RR 1.1, 95% CI 1.05-1.22%, p = 0.001) and increased with age, with an OR seropositivity of 1.03 for each 10-year increase in age (95% CI 1.00-1.06, p = 0.031). Close contact with COVID-19-infected individuals was associated with a higher risk of infection, especially among household members (OR 5.0, 95% CI 4.1-6.2 p < 0,001). Living at least four people in a household significantly increased the OR of seropositivity (OR 1.3, 95% CI 1.0-1.6, p = 0.02) as did living in a multi-generational household (OR 1.3 per generation, 95% CI 1.1-1.6, p = 0.003). Only 1.6% of participants reported not following any of the national COVID-19 recommendations. Conclusions Danish citizens living in SH areas of low socioeconomic status had a three times higher SARS-CoV-2 seroprevalence compared to the general Danish population. The seroprevalence was significantly higher in males and increased slightly with age. Living in multiple generations households or in households of more than four persons was a strong risk factor for being seropositive. Results of this study can be used for future consideration of the need for preventive measures in the populations living in SH areas.

KW - SARS-CoV-2

KW - COVID-19

KW - Seroprevalence

KW - Social housing areas

KW - Antibodies

U2 - 10.1186/s12879-022-07102-1

DO - 10.1186/s12879-022-07102-1

M3 - Journal article

C2 - 35144550

VL - 22

JO - B M C Infectious Diseases

JF - B M C Infectious Diseases

SN - 1471-2334

IS - 1

M1 - 143

ER -

ID: 299392937